Home

Screener

BDTX

Profile

BDTX Stock Price History and Quote Analysis: Insights for Investors

Black Diamond Therapeutics, Inc.

(NASDAQ:BDTX)

$2.23

-0.01 (-0.45%)

At Close: 4:00 PM

BDTX Stock Price Graph

BDTX Stock Price Today

Black Diamond Therapeutics, Inc. (BDTX) stock declined over -0.45% intraday to trade at $2.23 a share on NASDAQ. The stock opened with a loss of -15.18% at $1.90 and touched an intraday high of $1.92, falling -0.45% against the last close of $2.24. The Black Diamond Therapeutics, Inc. in stock market went to a low of $1.77 during the session.

BDTX Stock Snapshot

$2.24

Prev. Close

115.16 Million

Market Cap

$1.77

Day Low

$1.90

Open

N/A

Number of Shares

$1.92

Day High

N/A

P/E ratio

-2.13

EPS (TTM)

2.79

Cash Flow per Share

N/A

Free Float in %

2.60

Book Value

148011.00

Volume

BDTX Stock Price History Chart

Date	Open	High	Low	Close	Volume

Contact Details

One Main Street
Cambridge, MA 02142
US

Website:https://www.blackdiamondtherapeutics.com

Contact #:617 252 0848

About Company

Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver mutations. The company is also developing BDTX-1535, a brain-penetrant inhibitor of EGFR mutations, including canonical, intrinsic resistance, and acquired resistance mutations; and BDTX-4933, a brain-penetrant inhibitor of oncogenic BRAF class I, II and III alterations. It has a strategic partnership with OpenEye Scientific Software, Inc. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Peers

Frequently Asked Questions

What is the current Black Diamond Therapeutics, Inc. (BDTX) stock price?

Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) stock price is $2.23 in the last trading session. During the trading session, BDTX stock reached the peak price of $1.92 while $1.77 was the lowest point it dropped to. The percentage change in BDTX stock occurred in the recent session was -0.45% while the dollar amount for the price change in BDTX stock was -$0.01.

BDTX's industry and sector of operation?

The NASDAQ listed BDTX is part of Biotechnology industry that operates in the broader Healthcare sector. Black Diamond Therapeutics, Inc. , a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors.

Who are the executives of BDTX?

Mr. Tai-An Lin Ph.D.
Senior Vice President of Translational Science & Discovery Biology
Dr. Fang Ni Pharm.D.
Chief Financial Officer, Principal Financial Officer and Chief Bus. Officer
Ms. Erika Jones
Vice President of Fin., Corporation Controller & Principal Accounting Officer
Ms. Melanie Morrison
Senior Vice President of Devel. Operations

How BDTX did perform over past 52-week?

BDTX's closing price is 0.47% higher than its 52-week low of $1.22 where as its distance from 52-week high of $6.85 is -0.57%.

How many employees does BDTX have?

Number of BDTX employees currently stands at N/A. BDTX operates from One Main Street, Cambridge, MA 02142, US.

Link for BDTX official website?

Official Website of BDTX is: https://www.blackdiamondtherapeutics.com

How do I contact BDTX?

BDTX could be contacted at phone #617 252 0848 and can also be accessed through its website. BDTX operates from One Main Street, Cambridge, MA 02142, US.

How many shares of BDTX are traded daily?

BDTX stock volume for the day was 148011.00 shares. The average number of BDTX shares traded daily for last 3 months was 568.27 Thousands.

What is the market cap of BDTX currently?

The market value of BDTX currently stands at $115.16 Million with its latest stock price at $2.23 and N/A of its shares outstanding.